278 related articles for article (PubMed ID: 36755296)
1. Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
Cartas-Cejudo P; Lachén-Montes M; Ferrer I; Fernández-Irigoyen J; Santamaría E
Biol Sex Differ; 2023 Feb; 14(1):5. PubMed ID: 36755296
[TBL] [Abstract][Full Text] [Related]
2. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.
Lachén-Montes M; González-Morales A; Iloro I; Elortza F; Ferrer I; Gveric D; Fernández-Irigoyen J; Santamaría E
Neurobiol Aging; 2019 Jan; 73():123-134. PubMed ID: 30342273
[TBL] [Abstract][Full Text] [Related]
4. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
5. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
6. Possible role of endocannabinoids in olfactory and taste dysfunctions in Alzheimer's and Parkinson's patients and volumetric changes in the brain.
Petekkaya E; Kuş B; Doğan S; Bayaroğulları H; Mutlu T; Murat Melek İ; Arpacı A
J Clin Neurosci; 2022 Jun; 100():52-58. PubMed ID: 35398594
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis of the Human Olfactory Bulb.
Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK
OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642
[TBL] [Abstract][Full Text] [Related]
8. Olfactory dysfunction in Parkinson's disease.
Wszolek ZK; Markopoulou K
Clin Neurosci; 1998; 5(2):94-101. PubMed ID: 10785834
[TBL] [Abstract][Full Text] [Related]
9. Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.
Walker IM; Fullard ME; Morley JF; Duda JE
Handb Clin Neurol; 2021; 182():317-329. PubMed ID: 34266602
[TBL] [Abstract][Full Text] [Related]
10. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
[TBL] [Abstract][Full Text] [Related]
11. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
[TBL] [Abstract][Full Text] [Related]
12. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases.
Mesholam RI; Moberg PJ; Mahr RN; Doty RL
Arch Neurol; 1998 Jan; 55(1):84-90. PubMed ID: 9443714
[TBL] [Abstract][Full Text] [Related]
13. Olfactory dysfunction in aging and neurodegenerative diseases.
Dan X; Wechter N; Gray S; Mohanty JG; Croteau DL; Bohr VA
Ageing Res Rev; 2021 Sep; 70():101416. PubMed ID: 34325072
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
[TBL] [Abstract][Full Text] [Related]
15. Markers of brain illness may be hidden in your olfactory ability: a Japanese perspective.
Masaoka Y; Pantelis C; Phillips A; Kawamura M; Mimura M; Minegishi G; Homma I
Neurosci Lett; 2013 Aug; 549():182-5. PubMed ID: 23769725
[TBL] [Abstract][Full Text] [Related]
16. The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis.
Rahayel S; Frasnelli J; Joubert S
Behav Brain Res; 2012 May; 231(1):60-74. PubMed ID: 22414849
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
18. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
19. Patterns of olfactory functional networks in Parkinson's disease dementia and Alzheimer's dementia.
Lee YH; Bak Y; Park CH; Chung SJ; Yoo HS; Baik K; Jung JH; Sohn YH; Shin NY; Lee PH
Neurobiol Aging; 2020 May; 89():63-70. PubMed ID: 31980278
[TBL] [Abstract][Full Text] [Related]
20. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
